EP1254904A4 - Piperidinverbindungen und diese enthaltenden medikamente - Google Patents
Piperidinverbindungen und diese enthaltenden medikamenteInfo
- Publication number
- EP1254904A4 EP1254904A4 EP01901412A EP01901412A EP1254904A4 EP 1254904 A4 EP1254904 A4 EP 1254904A4 EP 01901412 A EP01901412 A EP 01901412A EP 01901412 A EP01901412 A EP 01901412A EP 1254904 A4 EP1254904 A4 EP 1254904A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- same
- piperidine compounds
- drugs containing
- formula
- novel piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000012175 | 2000-01-20 | ||
JP2000012175 | 2000-01-20 | ||
PCT/JP2001/000287 WO2001053288A1 (fr) | 2000-01-20 | 2001-01-18 | Nouveaux composes de piperidine et medicaments contenant ces composes |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1254904A1 EP1254904A1 (de) | 2002-11-06 |
EP1254904A4 true EP1254904A4 (de) | 2003-03-19 |
EP1254904B1 EP1254904B1 (de) | 2006-05-24 |
Family
ID=18539928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01901412A Expired - Lifetime EP1254904B1 (de) | 2000-01-20 | 2001-01-18 | Piperidinverbindungen und diese enthaltenden medikamente |
Country Status (17)
Country | Link |
---|---|
US (1) | US6784192B2 (de) |
EP (1) | EP1254904B1 (de) |
KR (1) | KR20020080378A (de) |
CN (1) | CN1395575A (de) |
AT (1) | ATE327230T1 (de) |
AU (1) | AU779442B2 (de) |
BR (1) | BR0107732A (de) |
CA (1) | CA2398388A1 (de) |
DE (1) | DE60119894D1 (de) |
HU (1) | HUP0204496A3 (de) |
IL (1) | IL150650A0 (de) |
MX (1) | MXPA02007036A (de) |
NO (1) | NO20023457L (de) |
NZ (1) | NZ520041A (de) |
RU (1) | RU2259365C2 (de) |
WO (1) | WO2001053288A1 (de) |
ZA (1) | ZA200205399B (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
AR037233A1 (es) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
AR036873A1 (es) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
US6995144B2 (en) | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
AR040336A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
KR20050114641A (ko) * | 2003-03-07 | 2005-12-06 | 아스텔라스세이야쿠 가부시키가이샤 | 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체 |
JP5025266B2 (ja) * | 2004-09-01 | 2012-09-12 | アステラス製薬株式会社 | ピペリジン誘導体又はその製薬学的に許容される塩 |
WO2006099541A2 (en) * | 2005-03-15 | 2006-09-21 | Richard Daniel Carliss | Therapeutic wound care product |
AU2006244072B2 (en) | 2005-05-10 | 2012-09-20 | Intermune, Inc. | Pyridone derivatives for modulating stress-activated protein kinase system |
WO2006132192A1 (ja) * | 2005-06-07 | 2006-12-14 | Dainippon Sumitomo Pharma Co., Ltd. | 新規2-キノロン誘導体 |
AU2006264043B2 (en) | 2005-06-28 | 2012-04-26 | Sanofi-Aventis | Isoquinoline derivatives as inhibitors of Rho-kinase |
PT1910333E (pt) | 2005-07-26 | 2013-08-01 | Sanofi Sa | Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase |
ATE521595T1 (de) | 2005-07-26 | 2011-09-15 | Sanofi Sa | Cyclohexylaminisochinolonderivate als rho-kinase- inhibitor |
JP5170386B2 (ja) * | 2005-08-18 | 2013-03-27 | 日産化学工業株式会社 | スルフォニル基を有するチオフェン化合物及びその製造法 |
WO2007027528A2 (en) | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
ATE528302T1 (de) | 2005-08-29 | 2011-10-15 | Vertex Pharma | 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind |
AU2006285038A1 (en) * | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases |
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
KR101124070B1 (ko) * | 2006-06-05 | 2012-04-12 | 제논 파마슈티칼스 인크. | 유기 화합물 |
MX2009005825A (es) | 2006-12-27 | 2009-06-16 | Sanofi Aventis | Derivados de isoquinolina e isoquinolinona sustituidos en calidad de inhibidores de rho-quinasa. |
DK2132194T3 (da) | 2006-12-27 | 2011-06-27 | Sanofi Aventis | Substituerede isoquinoliner og deres anvendelse som Rho-kinase inhibitorer |
NZ577980A (en) * | 2006-12-27 | 2012-01-12 | Sanofi Aventis | Cycloalkylamine substituted isoquinolone derivatives |
CN101573338B (zh) * | 2006-12-27 | 2013-03-20 | 塞诺菲-安万特股份有限公司 | 环烷基胺取代的异喹诺酮和异喹啉酮衍生物 |
CA2673920C (en) | 2006-12-27 | 2015-03-24 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline derivatives |
CA2673922C (en) | 2006-12-27 | 2015-09-29 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
KR20090094338A (ko) | 2006-12-27 | 2009-09-04 | 사노피-아벤티스 | 치환된 이소퀴놀린 및 이소퀴놀리논 유도체 |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
WO2008113006A1 (en) * | 2007-03-14 | 2008-09-18 | Xenon Pharmaceuticals Inc. | Methods of using quinolinone compounds in treating sodium channel-mediated diseases or conditions |
PL2152690T3 (pl) | 2007-05-23 | 2012-06-29 | Merck Sharp & Dohme | Pirydylo piperydynowi antagoniści receptora oreksyny |
CN101801951B (zh) | 2007-09-14 | 2013-11-13 | 杨森制药有限公司 | 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮 |
EP2241567A4 (de) | 2008-02-13 | 2011-11-09 | Eisai R&D Man Co Ltd | Bicycloamin-derivat |
US8304413B2 (en) | 2008-06-03 | 2012-11-06 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
RU2528229C2 (ru) * | 2008-06-24 | 2014-09-10 | Санофи-Авентис | 6-ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНЫ И ИЗОХИНОЛИНОНЫ ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ |
NZ590067A (en) * | 2008-06-24 | 2012-09-28 | Sanofi Aventis | Bi-and polycyclic substituted isoquinoline and isoquinolinone derivatives as rho kinase inhibitors |
WO2009156100A1 (en) * | 2008-06-24 | 2009-12-30 | Sanofi-Aventis | Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
US8357700B2 (en) | 2008-10-21 | 2013-01-22 | Merck Sharp & Dohme Corp. | 2,3-disubstituted piperidine orexin receptor antagonists |
CA2739915A1 (en) | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
ME01573B (me) | 2009-05-12 | 2014-09-20 | Addex Pharma Sa | DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA |
MX2011011962A (es) | 2009-05-12 | 2012-02-28 | Janssen Pharmaceuticals Inc | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2). |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
US8809380B2 (en) | 2009-08-04 | 2014-08-19 | Raqualia Pharma Inc. | Picolinamide derivatives as TTX-S blockers |
JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
AU2011328195B2 (en) | 2010-11-08 | 2015-04-02 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
US9034874B2 (en) * | 2012-07-20 | 2015-05-19 | Novartis Ag | Carbamate/urea derivatives |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
PL3096790T3 (pl) | 2014-01-21 | 2020-01-31 | Janssen Pharmaceutica, N.V. | Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie |
KR20200036063A (ko) | 2014-01-21 | 2020-04-06 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
EP3126362B1 (de) | 2014-04-02 | 2022-01-12 | Intermune, Inc. | Antifibrotische pyridinone |
JP2017206440A (ja) * | 2014-09-10 | 2017-11-24 | 日本曹達株式会社 | ピリジン化合物およびその用途 |
BR112018067628A2 (pt) | 2016-03-09 | 2018-12-26 | Nippon Soda Co., Ltd. | composto de piridina, fungicida agrícola e hortícola, agente de controle de organismo nocivo, agente inseticida ou acaricida, e, agente de controle de ectoparasita |
RS60209B1 (sr) | 2017-03-20 | 2020-06-30 | Forma Therapeutics Inc | Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr) |
CA3059273A1 (en) | 2017-04-10 | 2018-10-18 | Bayer Aktiengesellschaft | Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof |
WO2020061255A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
US20220031671A1 (en) | 2018-09-19 | 2022-02-03 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4665187A (en) * | 1984-10-19 | 1987-05-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Certain 1,2,3,6-tetrahydro-pyridyl-N-lower-alkanoyl-pyridines as intermediates |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2459240A1 (fr) | 1979-06-21 | 1981-01-09 | Cm Ind | Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent |
FR2467849A1 (fr) | 1979-10-17 | 1981-04-30 | Clin Midy | 4-amino-1-(2-pyridyl)piperidines n-substituees et leur procede de preparation |
PH23283A (en) | 1986-02-26 | 1989-06-30 | Eisai Co Ltd | Piperidine derivative, pharmaceutical composition containing the same and method of use thereof |
DK111387A (da) * | 1986-03-05 | 1987-09-06 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne |
AU639529B2 (en) * | 1987-03-04 | 1993-07-29 | Higuchi, Yoshinari | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
JPS6463518A (en) | 1987-09-02 | 1989-03-09 | Otsuka Pharma Co Ltd | Antiarrhythmic agent |
GB8820174D0 (en) | 1988-08-25 | 1988-09-28 | Wellcome Found | Quinoline compound |
JPH02264773A (ja) | 1989-04-04 | 1990-10-29 | Ikeda Mohandou:Kk | ベンゾイルピペリジン誘導体及びその塩 |
AU650031B2 (en) | 1990-06-07 | 1994-06-09 | Aventisub Ii Inc. | 1-Piperidinyl alkanoylarylsulfonamide derivatives |
EP0506545B1 (de) | 1991-03-27 | 1998-12-30 | Sanofi | Verwendung von 4-Amino-1-(2-Pyridyl)Piperidinen als 5-HT3-Agonisten zur Behandlung und Verhütung von serotoninergen Dysfunktionen |
US5240943A (en) | 1991-12-19 | 1993-08-31 | G. D. Searle & Co. | Benzopyran class iii antiarrhythmic agents |
US5457099A (en) * | 1992-07-02 | 1995-10-10 | Sawai Pharmaceutical Co., Ltd. | Carbostyril derivatives and antiallergic agent |
TW282469B (de) | 1993-06-11 | 1996-08-01 | Janssen Pharmaceutica Nv | |
ATE216580T1 (de) | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
DK0730581T3 (da) | 1993-11-22 | 2001-11-26 | Merck & Co Inc | 3-acylaminobezazepiner |
US5639763A (en) | 1994-03-01 | 1997-06-17 | Fmc Corporation | Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
FR2726267B1 (fr) | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
EP0850235B1 (de) | 1995-09-15 | 1999-12-01 | Sanofi-Synthelabo | Chinolin-2-on derivate als serotonin antagonisten |
ATE205490T1 (de) | 1995-10-13 | 2001-09-15 | Banyu Pharma Co Ltd | Substituierte heteroaromatische derivate |
EP0934932A4 (de) | 1996-08-22 | 2002-06-26 | Meiji Seika Kaisha | Chinolinderivate und psychotropes mittel |
FR2761067B1 (fr) | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
US5987429A (en) | 1997-12-16 | 1999-11-16 | Sun Microsystems, Inc. | Computer-based fee processing for electronic commerce |
JP4321737B2 (ja) * | 1997-12-17 | 2009-08-26 | 塩野義製薬株式会社 | 新規ピリジン化合物 |
US6855726B1 (en) * | 1998-03-31 | 2005-02-15 | Warner-Lambert Company Llc | Quinolones as serine protease inhibitors |
CN1149214C (zh) | 1998-12-04 | 2004-05-12 | 东丽株式会社 | 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂 |
DE10054641A1 (de) | 2000-11-03 | 2002-05-16 | Schaper & Bruemmer Gmbh | Verwendung einer Zubereitung von Cimicifuga racemosa |
-
2001
- 2001-01-18 IL IL15065001A patent/IL150650A0/xx unknown
- 2001-01-18 MX MXPA02007036A patent/MXPA02007036A/es active IP Right Grant
- 2001-01-18 CA CA002398388A patent/CA2398388A1/en not_active Abandoned
- 2001-01-18 WO PCT/JP2001/000287 patent/WO2001053288A1/ja active IP Right Grant
- 2001-01-18 EP EP01901412A patent/EP1254904B1/de not_active Expired - Lifetime
- 2001-01-18 RU RU2002122095/04A patent/RU2259365C2/ru not_active IP Right Cessation
- 2001-01-18 NZ NZ520041A patent/NZ520041A/en unknown
- 2001-01-18 AT AT01901412T patent/ATE327230T1/de not_active IP Right Cessation
- 2001-01-18 DE DE60119894T patent/DE60119894D1/de not_active Expired - Lifetime
- 2001-01-18 HU HU0204496A patent/HUP0204496A3/hu unknown
- 2001-01-18 KR KR1020027009265A patent/KR20020080378A/ko not_active Application Discontinuation
- 2001-01-18 AU AU27058/01A patent/AU779442B2/en not_active Ceased
- 2001-01-18 US US10/181,560 patent/US6784192B2/en not_active Expired - Fee Related
- 2001-01-18 CN CN01803949A patent/CN1395575A/zh active Pending
- 2001-01-18 BR BR0107732-5A patent/BR0107732A/pt not_active IP Right Cessation
-
2002
- 2002-07-05 ZA ZA200205399A patent/ZA200205399B/en unknown
- 2002-07-18 NO NO20023457A patent/NO20023457L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4665187A (en) * | 1984-10-19 | 1987-05-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Certain 1,2,3,6-tetrahydro-pyridyl-N-lower-alkanoyl-pyridines as intermediates |
Also Published As
Publication number | Publication date |
---|---|
AU779442B2 (en) | 2005-01-27 |
RU2259365C2 (ru) | 2005-08-27 |
ATE327230T1 (de) | 2006-06-15 |
CN1395575A (zh) | 2003-02-05 |
US6784192B2 (en) | 2004-08-31 |
NO20023457D0 (no) | 2002-07-18 |
AU2705801A (en) | 2001-07-31 |
NO20023457L (no) | 2002-09-13 |
IL150650A0 (en) | 2003-02-12 |
NZ520041A (en) | 2004-11-26 |
CA2398388A1 (en) | 2001-07-26 |
DE60119894D1 (de) | 2006-06-29 |
HUP0204496A2 (en) | 2003-05-28 |
WO2001053288A1 (fr) | 2001-07-26 |
EP1254904A1 (de) | 2002-11-06 |
ZA200205399B (en) | 2003-09-04 |
HUP0204496A3 (en) | 2004-07-28 |
KR20020080378A (ko) | 2002-10-23 |
BR0107732A (pt) | 2003-03-11 |
EP1254904B1 (de) | 2006-05-24 |
US20030220368A1 (en) | 2003-11-27 |
MXPA02007036A (es) | 2002-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1254904A4 (de) | Piperidinverbindungen und diese enthaltenden medikamente | |
EP1217001A4 (de) | Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten | |
EP1254659A4 (de) | Stabile emulsionszubereitungen | |
EP1380576A4 (de) | Neue 1h-indazolverbindung | |
EP1254895A4 (de) | Stickstoffhaltige cyclische verbindungen und sie enthaltende pharmazeutische zubereitungen | |
GB0123589D0 (en) | Organic compounds | |
PL344048A1 (en) | Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them | |
EP1484327A4 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
HK1065030A1 (en) | Unsymetrical cyclic diamine compound | |
AU7824900A (en) | Compounds and methods for inhibiting mrp1 | |
EP1304324A4 (de) | Serotoninwiederaufnahme-inhibitoren | |
TW427979B (en) | A condensed piperidine compound | |
AP2000002008A0 (en) | Tetrahydroquinoline derivatives as glycine antagonists. | |
IL157440A0 (en) | Triazole derivatives and pharmaceutical compositions containing the same | |
MY129094A (en) | Condensed polycyclic compounds | |
EP1338596A4 (de) | Verfahren zur herstellung antibakterieller verbindungen vom carbapenem-typ | |
EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
IL151880A0 (en) | Triazole derivatives and pharmaceutical compositions containing the same | |
MY133207A (en) | Substituted benzolactam compaunds | |
EP1433480A4 (de) | Pyrimidinderivate enthaltendes medikament | |
TW200504048A (en) | Cyclic onium compounds and glucosidase inhibitors | |
EP1557407A4 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
IL140751A0 (en) | Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them | |
EP0791581A4 (de) | Uch-verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020712 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030130 |
|
17Q | First examination report despatched |
Effective date: 20030430 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20060524 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60119894 Country of ref document: DE Date of ref document: 20060629 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060824 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060825 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060904 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061024 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070131 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20070227 |
|
EN | Fr: translation not filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060825 Ref country code: FR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070309 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070118 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060524 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20110120 Year of fee payment: 11 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20120118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120118 |